<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONSOLIDATED BALANCE SHEET AS OF 12/31/94 AND CONSOLIDATED STATEMENT OF INCOME FOR YEAR ENDED 12/31/94 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <MULTIPLIER> 1,000,000 <CURRENCY> U.S. DOLLARS <PERIOD-TYPE> YEAR <FISCAL-YEAR-END> DEC-31-1994 <PERIOD-START> JAN-01-1994 <PERIOD-END> DEC-31-1994 <EXCHANGE-RATE> 1 <CASH> 471 <SECURITIES> 0 <RECEIVABLES> 1,955 <ALLOWANCES> 39 <INVENTORY> 1,537 <CURRENT-ASSETS> 4,340 <PP&E> 4,431 <DEPRECIATION> 1,869 <TOTAL-ASSETS> 10,002 <CURRENT-LIABILITIES> 2,766 <BONDS> 2,341 <COMMON> 288 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <OTHER-SE> 3,432 <TOTAL-LIABILITY-AND-EQUITY> 10,002 <SALES> 9,324 <TOTAL-REVENUES> 9,324 <CGS> 6,032 <TOTAL-COSTS> 6,032 <OTHER-EXPENSES> 410<F1> <LOSS-PROVISION> 14 <INTEREST-EXPENSE> 237 <INCOME-PRETAX> 801 <INCOME-TAX> 205 <INCOME-CONTINUING> 596 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 596 <EPS-PRIMARY> 2.13 <EPS-DILUTED> 2.11 <FN> <F1> Includes R&D expense and goodwill amortization. </FN>